Impact of CDX2 expression status on the survival of patients after curative resection for colorectal cancer liver metastasis.

Yasuyuki ShigematsuKentaro InamuraNoriko YamamotoYoshihiro MiseAkio SaiuraYuichi IshikawaShunji TakahashiHiroaki Kanda

Published in: BMC cancer (2018)

Reduced expression of CDX2 indicates poor DFS and OS, however, it might not represent chemosensitivity in patients undergoing curative liver metastasectomy. (339/350).

Keyphrases

poor prognosis
prognostic factors
patients undergoing
end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
rectal cancer
binding protein
peritoneal dialysis
patient reported outcomes